country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

On the neuropharmacology of harmane and other beta-carbolines

Pharmacol Biochem Behav. 1981 May;14(5):693-9. doi: 10.1016/0091-3057(81)90133-7.

W E Müller , K J Fehske , H O Borbe , U Wollert , C Nanz , H Rommelspacher

PMID: 6264501 DOI: 10.1016/0091-3057(81)90133-7

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-101392

Harmane

99.91%, MAO Inhibitor

target: Imidazoline Receptor; Monoamine Oxidase; Adrenergic Receptor; nAChR; GABA Receptor; Opioid Receptor

Research Areas: Neurological Disease; Inflammation/Immunology
HY-101392A

Harmane hydrochloride

99.88%, MAO Inhibitor

target: Imidazoline Receptor; Monoamine Oxidase; Adrenergic Receptor; nAChR; GABA Receptor; Opioid Receptor

Research Areas: Neurological Disease; Inflammation/Immunology
HY-W777360

Harman-¹³C₂,¹⁵N

99.66%, Stable Isotope

target: nAChR; Adrenergic Receptor; Opioid Receptor; Monoamine Oxidase; GABA Receptor; Imidazoline Receptor; Isotope-Labeled Compounds

Research Areas: Neurological Disease; Inflammation/Immunology
HY-W700834

Harman-d₃

Stable Isotope

target: Isotope-Labeled Compounds

Research Areas: Neurological Disease; Inflammation/Immunology